- Understand current evidence about benefit and safety of bisphosphonates, and the limitations of the evidence

- Consider the approach to discussing bisphosphonate options with patients, incorporating communication of the evidence with patient views and preferences
  • 1624114090-22fa98ed659fda86
    Dr Zoe Paskins
    Reader; Honorary Consultant Rheumatologist; and NIHR Clinician Scientist, Keele University

    Zoe is an honorary consultant rheumatologist at the Haywood Rheumatology Centre in Stoke-on-Trent; clinical lead for the North Staffordshire Osteoporosis Service; and a reader at the Primary Care Centre Versus Arthritis at Keele University. She leads the Keele Osteoporosis Research Group, and holds a NIHR Clinician Scientist Award to develop a decision support tool in osteoporosis. She chairs the Midlands Bone Interest Group; is a member of the National Osteoporosis Guideline Group & the International Patient Decision Aids Standards Collaboration; committee member for Versus Arthritis; and Vice Chair of the Royal Osteoporosis Society Bone Academy Effectiveness working group.